NewEdge Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50
| Closed | -$1.6K | – | 3961 |
|
|
2024
Q4 | $1.6K | Hold |
50
| – | – | ﹤0.01% | 3490 |
|
|
2024
Q3 | $1.44K | Hold |
50
| – | – | ﹤0.01% | 3450 |
|
|
2024
Q2 | $1.92K | Sell |
50
-176
| -78% | -$6.75K | ﹤0.01% | 3344 |
|
|
2024
Q1 | $13.3K | Sell |
226
-27
| -11% | -$1.59K | ﹤0.01% | 2774 |
|
|
2023
Q4 | $15.1K | Buy |
+253
| New | +$15.1K | ﹤0.01% | 2688 |
|
|
2023
Q1 | – | Sell |
-200
| Closed | -$10.3K | – | 3443 |
|
|
2022
Q4 | $10.3K | Buy |
+200
| New | +$10.3K | ﹤0.01% | 2363 |
|